Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis

Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis

Background Using infliximab (IFX), an antitumor necrosis factors antibody, has dramatically increased therapeutic choices for ulcerative colitis (UC). This study assessed IFX therapy’s efficacy, safety, and action predictor variables for UC. Patients and methods This prospective interventional study...

Full description

Bibliographic Details
Main Authors: Mohamed G Fawaz, Khaled A.A Eid, Mohamed F Mohamed
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Al-Azhar Assiut Medical Journal
Subjects:
efficacy
infliximab
predictors of response
safety
ulcerative colitis
Online Access:http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2022;volume=20;issue=2;spage=177;epage=184;aulast=Fawaz

Similar Items

Similar Items